MedPacto, Inc. logo

MedPacto, Inc.

MedPacto Inc. researches, develops, and manufactures oncology therapeutics. The company offers TEW-7197 and TEW-0201, the anti-cancer drugs which help to suppress tumor growth; and DKK2, an angiogenesis-promoting protein which helps in the formation of blood vessels to cure ulcer or neuropathy caused by diabetes.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.medpacto.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
145 Gwanggyo-roAdvanced Institutes of Convergence Technology Building C, 5th floor, Room 50616229
Suwon
South Korea
Email
Contact Number
+82-31-888-9928

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]